Active Ingredient: Semaglutide (a synthetic version of the GLP-1 hormone) Inactive Ingredients: Disodium phosphate Propylene glycol Phenol Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injection Semaglutide is the active ingredient contained within Wegovy and the dose of semaglutide contained within the pen will vary depending upon the strength of Wegovy selected Common side effects may include: Headache Nausea Vomiting Diarrhea Constipation Abdominal pain Fatigue Serious side effects to be aware of: Risk of thyroid tumours, including cancer (medullary thyroid carcinoma) Severe allergic reactions (e.g., difficulty breathing, rapid heartbeat) Pancreatitis Most side effects are mild and often improve over time
Does insurance cover Zevay TRT
UKU, Udvalg for Kliniske Undersgelser Side Effect Rating Scale
The material must be clearly labeled as not for human consumption and accompanied by documentation establishing its research-use intent
GLP-3RT is a research-grade triple agonist peptide that activates GLP-1, GIP, and glucagon receptors
In addition, DKT was found to suppress the visceromotor response to colorectal distention in rats treated with DSS and TNBS
